BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6124066)

  • 1. [In situ - demonstration of helper-T-lymphocytes in cutaneous malignant lymphomas by diaminopeptidase IV (DAP IV)].
    Sterry W; Steigleder GK; Goos M; Meisterernst E
    Z Hautkr; 1982 Apr; 57(8):567-76. PubMed ID: 6124066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunological characterization of malignant epidermotropic lymphoma cells in cutaneous infiltrates (author's transl)].
    Thivolet J; Souteyrand P; Alario A; Schmitt D; Perrot H
    Dermatologica; 1978; 157(6):357-64. PubMed ID: 363474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ identification and enumeration of helper T lymphocytes in cutaneous malignant lymphomas by dipeptidyl-peptidase IV (DPP IV).
    Sterry W; Steigleder GK; Goos M; Meisterernst E
    J Cutan Pathol; 1982 Apr; 9(2):119-20. PubMed ID: 7047598
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dipeptidyl aminopeptidase-IV in lymphocytes of patients with lymphoproliferative diseases].
    Bylinkina VS; Golubeva NV; Gureeva TA; Lokshina LA; Polianskaia AM; Samoĭlova RS
    Biull Eksp Biol Med; 1989 Jul; 108(7):85-8. PubMed ID: 2572281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD7 expression in reactive and malignant human skin T-lymphocytes.
    Alaibac M; Pigozzi B; Belloni-Fortina A; Michelotto A; Saponeri A; Peserico A
    Anticancer Res; 2003; 23(3B):2707-10. PubMed ID: 12894562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the cutaneous T cell lymphomas.
    Edelson RL
    Bull Cancer; 1977; 64(2):209-24. PubMed ID: 303131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases.
    Novelli M; Savoia P; Fierro MT; Verrone A; Quaglino P; Bernengo MG
    Br J Dermatol; 1996 Jun; 134(6):1052-6. PubMed ID: 8763423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections.
    Izban KF; Hsi ED; Alkan S
    Mod Pathol; 1998 Oct; 11(10):978-82. PubMed ID: 9796726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ultrastructural morphometric and immunohistochemical analysis of cutaneous lymphomas and benign lymphocytic infiltrates of skin. Useful criteria for diagnosis.
    Payne CM; Grogan TM; Lynch PJ
    Arch Dermatol; 1986 Oct; 122(10):1139-54. PubMed ID: 3490225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymehistochemical staining of T mu lymphocytes for glycyl-proline-4-methoxy-beta-naphthylamide-peptidase (DAP IV).
    Feller AC; Heijnen CJ; Ballieux RE; Parwaresch MR
    Br J Haematol; 1982 Jun; 51(2):227-34. PubMed ID: 6123345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity of T cells in mycosis fungoides exhibiting marked epidermotropism with the monoclonal antibody HML-1 that defines a membrane molecule on human mucosal lymphocytes.
    Sperling M; Kaudewitz P; Braun-Falco O; Stein H
    Am J Pathol; 1989 May; 134(5):955-60. PubMed ID: 2785762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunocytological study of cutaneous malignant lymphomas. Classification (author's transl)].
    Souteyrand P; Thivolet J; Alario A; Schmitt D; Perrot H
    Dermatologica; 1978; 157(5):268-81. PubMed ID: 150348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of cutaneous lymphomas. Histological, enzyme cytochemical, and immunological typing of lymphoreticular proliferations in the skin.
    Burg G; Braun-Falco O; Hoffmann-Fezer G; Rodt H; Schmoeckel C
    Dermatologica; 1978; 157(5):282-91. PubMed ID: 150349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--part II.
    Safai B
    Clin Bull; 1977; 7(4):140-5. PubMed ID: 147147
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.
    Moore PF; Olivry T; Naydan D
    Am J Pathol; 1994 Feb; 144(2):421-9. PubMed ID: 7906096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Manifestation of a malignant lymphoma of high grade malignancy in the terminal stage of mycosis fungoides. Enzyme-cytochemical and immunocytological investigations (author's transl)].
    Büchner S; Rufli T
    Dermatologica; 1979; 159(2):125-31. PubMed ID: 383532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subpopulations of T lymphocytes in a patient with fulminant mycosis fungoides.
    Jensen JR; Thestrup-Pedersen K
    Acta Derm Venereol; 1980; 60(2):159-61. PubMed ID: 6155025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunologic phenotyping of cutaneous lymphomas].
    Kaudewitz P; Burg G; Smolle J; Braun-Falco O
    Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.